Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells

Open access
Marchand, Benoît, Arsenault, Dominique, Raymond-Fleury, Alexandre, Boisvert, François-Michel, Boucher, Marie-Josée·2015·Journal of Biological Chemistry

Abstract

Glycogen synthase kinase-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ranging from the control of glycogen metabolism to transcriptional regulation. We recently demonstrated that GSK3 inhibition triggers JNK-cJUN-dependent apoptosis in human pancreatic cancer cells. However, the comprehensive picture of downstream GSK3-regulated pathways/functions remains elusive. Herein, counterbalancing the death signals, we show that GSK3 inhibition induces prosurvival signals through increased activity of the autophagy/lysosomal network. Our data also reveal a contribution of GSK3 in the regulation of the master transcriptional regulator of autophagy and lysosomal biogenesis, transcription factor EB (TFEB) in pancreatic cancer cells. Similarly to mammalian target of rapamycin (mTOR) inhibition, GSK3 inhibitors promote TFEB nuclear localization and leads to TFEB dephosphorylation through endogenous serine/threonine phosphatase action. However, GSK3 and mTOR inhibition impinge differently and independently on TFEB phosphorylation suggesting that TFEB is regulated by a panel of kinases and/or phosphatases. Despite their differential impact on TFEB phosphorylation, both GSK3 and mTOR inhibitors promote 14-3-3 dissociation and TFEB nuclear localization. Quantitative mass spectrometry analyses further reveal an increased association of TFEB with nuclear proteins upon GSK3 and mTOR inhibition suggesting a positive impact on TFEB transcriptional function. Finally, a predominant nuclear localization of TFEB is unveiled in fully fed pancreatic cancer cells, whereas a reduction in TFEB expression significantly impairs their capacity for growth in an anchorage-independent manner. In addition, TFEB-restricted cells are more sensitive to apoptosis upon GSK3 inhibition. Altogether, our data uncover new functions under the control of GSK3 in pancreatic cancer cells in addition to providing key insight into TFEB regulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m114.616714

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 49

  1. Bardeesy, 2002, Pancreatic cancer biology and genetics, Nat. Rev. Cancer, 2, 897, 10.1038/nrc949 · DOI · Paper page
  2. Hezel, 2006, Genetics and biology of pancreatic ductal adenocarcinoma, Genes Dev, 20, 1218, 10.1101/gad.1415606 · DOI · Paper page
  3. Schneider, 2005, Pancreatic cancer: basic and clinical aspects, Gastroenterology, 128, 1606, 10.1053/j.gastro.2005.04.001 · DOI · Paper page
  4. Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
  5. Bang, 2013, GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB, Cancer Discov, 3, 690, 10.1158/2159-8290.CD-12-0541 · DOI
  6. Kitano, 2013, Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy, PloS One, 8, e55289, 10.1371/journal.pone.0055289 · DOI
  7. Mamaghani, 2009, Glycogen synthase kinase-3 inhibition disrupts nuclear factor-κB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy, BMC Cancer, 9, 132, 10.1186/1471-2407-9-132 · DOI
  8. Marchand, 2012, Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms, Carcinogenesis, 33, 529, 10.1093/carcin/bgr309 · DOI
  9. Ougolkov, 2005, Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells, Cancer Res, 65, 2076, 10.1158/0008-5472.CAN-04-3642 · DOI · Paper page
  10. Wilson, 2008, Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer, Cancer Res, 68, 8156, 10.1158/0008-5472.CAN-08-1061 · DOI
  11. Miyashita, 2009, An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3β, Anticancer Agents Med. Chem, 9, 1114, 10.2174/187152009789734982 · doi:10.2174/187152009789734982
  12. Zhang, 2014, Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells, Cell Death Dis, 5, e1142, 10.1038/cddis.2014.102 · DOI
  13. Lin, 2012, GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy, Science, 336, 477, 10.1126/science.1217032 · DOI · Paper page
  14. Parr, 2012, Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein, Mol. Cell. Biol, 32, 4410, 10.1128/MCB.00930-12 · DOI
  15. Yang, 2010, GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death, J. Cell Sci, 123, 861, 10.1242/jcs.060475 · DOI
  16. Lamb, 2013, The autophagosome: origins unknown, biogenesis complex, Nat. Rev. Mol. Cell Biol, 14, 759, 10.1038/nrm3696 · DOI · Paper page
  17. Strohecker, 2014, Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism, Autophagy, 10, 384, 10.4161/auto.27320 · DOI
  18. Guo, 2013, Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis, Genes Dev, 27, 1447, 10.1101/gad.219642.113 · DOI · Paper page
  19. Liu, 2012, Autophagy and cancer: issues we need to digest, J. Cell Sci, 125, 2349
  20. Mukubou, 2010, The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation, Int. J. Oncol, 37, 821
  21. Pardo, 2010, Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells, Pancreatology, 10, 19, 10.1159/000264680 · DOI
  22. Hashimoto, 2014, Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs, Eur. J. Cancer, 50, 1382, 10.1016/j.ejca.2014.01.011 · DOI
  23. Papademetrio, 2013, Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine, Target. Oncol, 9, 123, 10.1007/s11523-013-0278-5 · DOI
  24. Donohue, 2013, The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model, J. Cancer, 4, 585, 10.7150/jca.7030 · DOI
  25. Furukawa, 1996, Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16, Am. J. Pathol, 148, 1763
  26. Ouyang, 2000, Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype, Am. J. Pathol, 157, 1623, 10.1016/S0002-9440(10)64800-6 · DOI · Paper page
  27. Hoeflich, 2000, Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation, Nature, 406, 86, 10.1038/35017574 · DOI · Paper page
  28. Zhou, 2013, Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion, Cell Res, 23, 508, 10.1038/cr.2013.11 · DOI · Paper page
  29. Yang, 2011, A critical role for autophagy in pancreatic cancer, Autophagy, 7, 912, 10.4161/auto.7.8.15762 · DOI
  30. Maes, 2013, Autophagy: shaping the tumor microenvironment and therapeutic response, Trends Mol. Med, 19, 428, 10.1016/j.molmed.2013.04.005 · DOI · Paper page
  31. Settembre, 2013, Signals from the lysosome: a control centre for cellular clearance and energy metabolism, Nat. Rev. Mol. Cell Biol, 14, 283, 10.1038/nrm3565 · DOI · Paper page
  32. Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci. Signal, 5, ra42, 10.1126/scisignal.2002790 · DOI · Paper page
  33. Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, 8, 903, 10.4161/auto.19653 · DOI · Paper page
  34. Martina, 2013, Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes, J. Cell Biol, 200, 475, 10.1083/jcb.201209135 · DOI · Paper page
  35. Garcea, 2007, Glycogen synthase kinase-3β: a new target in pancreatic cancer?, Curr. Cancer Drug Targ, 7, 209, 10.2174/156800907780618266 · DOI
  36. Billadeau, 2007, Primers on molecular pathways: the glycogen synthase kinase-3β, Pancreatology, 7, 398, 10.1159/000108955 · DOI
  37. Martinez, 2008, Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs, Med. Res. Rev, 28, 773, 10.1002/med.20119 · DOI
  38. Cohen, 2004, GSK3 inhibitors: development and therapeutic potential, Nat. Rev. Drug Disc, 3, 479, 10.1038/nrd1415 · DOI · Paper page
  39. Lee, 2011, The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nat. Rev. Nephrol, 7, 718, 10.1038/nrneph.2011.150 · DOI · Paper page
  40. Hong, 2010, Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization, PloS One, 5, e15793, 10.1371/journal.pone.0015793 · DOI · Paper page
  41. Martina, 2014, The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris, Sci. Signal, 7, ra9, 10.1126/scisignal.2004754 · DOI · Paper page
  42. Pan, 2014, Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma, J. Proteome Res, 13, 1293, 10.1021/pr4010184 · DOI
  43. Efeyan, 2013, Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival, Nature, 493, 679, 10.1038/nature11745 · DOI · Paper page
  44. Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J, 31, 1095, 10.1038/emboj.2012.32 · DOI · Paper page
  45. Olsen, 2010, Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis, Sci. Signal, 3, ra3, 10.1126/scisignal.2000475 · DOI · Paper page
  46. Dephoure, 2008, A quantitative atlas of mitotic phosphorylation, Proc. Natl. Acad. Sci. U.S.A, 105, 10762, 10.1073/pnas.0805139105 · DOI · Paper page
  47. Chen, 2009, CDC25B mediates rapamycin-induced oncogenic responses in cancer cells, Cancer Res, 69, 2663, 10.1158/0008-5472.CAN-08-3222 · DOI
  48. Kettenbach, 2011, Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells, Sci. Signal, 4, rs5, 10.1126/scisignal.2001497 · DOI · Paper page
  49. Haq, 2011, Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer, J. Clin. Oncol, 29, 3474, 10.1200/JCO.2010.32.6223 · DOI

Cited by

See all 168

Metadata

Authors
Marchand, B., Arsenault, D., Raymond-Fleury, A., Boisvert, F.-M., & Boucher, M.-J.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2015-02
Volume
290
Issue
9
Pages
5592-5605
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1989548729
Cited by
168
References
11
FWCI
13.07
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells. https://app.cochat.ai/papers/10.1074/jbc.m114.616714
The paper
Marchand, B., Arsenault, D., Raymond-Fleury, A., Boisvert, F.-M., & Boucher, M.-J. (2015). Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m114.616714

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.